ATE454454T1 - Multifunktionelle und multivalente angiogenese- inhibitoren - Google Patents
Multifunktionelle und multivalente angiogenese- inhibitorenInfo
- Publication number
- ATE454454T1 ATE454454T1 AT05806365T AT05806365T ATE454454T1 AT E454454 T1 ATE454454 T1 AT E454454T1 AT 05806365 T AT05806365 T AT 05806365T AT 05806365 T AT05806365 T AT 05806365T AT E454454 T1 ATE454454 T1 AT E454454T1
- Authority
- AT
- Austria
- Prior art keywords
- multifunctional
- angiogenesis inhibitors
- multivalent
- angiogenesis
- inhibitors
- Prior art date
Links
- 229940121369 angiogenesis inhibitor Drugs 0.000 title abstract 2
- 239000004037 angiogenesis inhibitor Substances 0.000 title abstract 2
- 230000033115 angiogenesis Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000003112 inhibitor Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 238000006384 oligomerization reaction Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
- 201000003068 rheumatic fever Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200402635A ES2325344B1 (es) | 2004-11-02 | 2004-11-02 | Inhibidores de angiogenesis multifuncionales y multivalentes. |
PCT/EP2005/011714 WO2006048252A1 (en) | 2004-11-02 | 2005-10-31 | Multifunctional and multivalent angiogenesis inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE454454T1 true ATE454454T1 (de) | 2010-01-15 |
Family
ID=35592070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05806365T ATE454454T1 (de) | 2004-11-02 | 2005-10-31 | Multifunktionelle und multivalente angiogenese- inhibitoren |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070253952A1 (de) |
EP (1) | EP1814993B1 (de) |
JP (1) | JP2008527974A (de) |
CN (1) | CN101065486B (de) |
AT (1) | ATE454454T1 (de) |
AU (1) | AU2005300737B2 (de) |
BR (1) | BRPI0517928A (de) |
CA (1) | CA2585282A1 (de) |
DE (1) | DE602005018812D1 (de) |
ES (2) | ES2325344B1 (de) |
PT (1) | PT1814993E (de) |
RU (1) | RU2398878C2 (de) |
WO (1) | WO2006048252A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8580755B2 (en) * | 2008-02-19 | 2013-11-12 | University Of Rochester | Methods and compositions for treating inflammatory conditions |
TW201012473A (en) * | 2008-09-22 | 2010-04-01 | Tty Biopharm Co Ltd | Composition of inhibiting pathological angiogenesis |
WO2010122181A1 (es) * | 2009-04-20 | 2010-10-28 | Universidad Autónoma de Madrid | Proteínas oligoméricas y sus aplicaciones |
US9503931B2 (en) | 2009-08-12 | 2016-11-22 | Qualcomm Incorporated | Enhancements to the MU-MIMO VHT preamble to enable mode detection |
CN102802658A (zh) * | 2009-12-21 | 2012-11-28 | 台湾东洋药品工业股份有限公司 | 白细胞衍生趋化因子2于肿瘤细胞内降低肝细胞生长因子受体的磷酸化相关的方法与组合物 |
EP2420253A1 (de) | 2010-08-20 | 2012-02-22 | Leadartis, S.L. | Manipulation multifunktioneller und multivalenter Moleküle mit Kollagen-XV-Trimerisationsdomäne |
ES2701445T3 (es) | 2010-10-15 | 2019-02-22 | Leadartis S L | Generación de complejos polipeptídicos multifuncionales y multivalentes mediante el dominio de trimerización del colágeno XVIII |
EP2441776A1 (de) | 2010-10-15 | 2012-04-18 | Leadartis, S.L. | Erzeugung multifunktionaler und multivalenter Polypeptidkomplexe mit Kollagen-XVIII-Trimerisationsdomäne |
EP2561888A1 (de) * | 2011-08-23 | 2013-02-27 | Deutsches Krebsforschungszentrum | Protein enthaltend NC-1 zur Behandlung von Erkrankungen in Bezug auf Angiogenese |
CN108430489B (zh) * | 2015-06-28 | 2022-03-25 | 新源生物科技股份有限公司 | 用于抑制血管新生的融合蛋白 |
CN116249709A (zh) | 2020-06-05 | 2023-06-09 | 皮里斯制药有限公司 | 靶向4-1bb的多聚体免疫调节剂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2312287A1 (en) * | 1997-12-08 | 1999-06-17 | Beth Israel Deaconess Medical Center | Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
HUP0103329A3 (en) * | 1998-08-25 | 2003-09-29 | Lexigen Pharmaceuticals Corp L | Expression and export of angiostatin and endostatin as immunofusis |
DE19900743A1 (de) * | 1999-01-12 | 2000-07-13 | Aventis Pharma Gmbh | Neue komplexbildende Proteine |
KR100816572B1 (ko) * | 1999-04-28 | 2008-03-24 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 항-vegf 항체 및 이를 포함하는 약제학적 조성물 |
WO2003066078A1 (en) * | 2002-02-07 | 2003-08-14 | Delta Biotechnology Limited | Hiv inhibiting proteins |
AU2003234274A1 (en) * | 2002-04-26 | 2003-11-10 | California Institute Of Technology | D1-1 nucleic acids, polypeptides and related methods |
US20040081647A1 (en) * | 2002-08-27 | 2004-04-29 | Afeyan Noubar B. | Adzymes and uses thereof |
US20050008649A1 (en) * | 2003-06-02 | 2005-01-13 | University Of Miami | Chimeric molecules and methods of use |
EP1819359B1 (de) * | 2004-12-09 | 2015-03-18 | Janssen Biotech, Inc. | Anti-integrin-immunkonjugate, verfahren für deren herstellung und deren verwendung |
-
2004
- 2004-11-02 ES ES200402635A patent/ES2325344B1/es active Active
-
2005
- 2005-10-31 EP EP05806365A patent/EP1814993B1/de active Active
- 2005-10-31 US US11/718,390 patent/US20070253952A1/en not_active Abandoned
- 2005-10-31 AU AU2005300737A patent/AU2005300737B2/en not_active Ceased
- 2005-10-31 AT AT05806365T patent/ATE454454T1/de not_active IP Right Cessation
- 2005-10-31 CN CN2005800381233A patent/CN101065486B/zh not_active Expired - Fee Related
- 2005-10-31 RU RU2007120521/13A patent/RU2398878C2/ru not_active IP Right Cessation
- 2005-10-31 CA CA002585282A patent/CA2585282A1/en not_active Abandoned
- 2005-10-31 WO PCT/EP2005/011714 patent/WO2006048252A1/en active Application Filing
- 2005-10-31 JP JP2007539527A patent/JP2008527974A/ja active Pending
- 2005-10-31 DE DE602005018812T patent/DE602005018812D1/de active Active
- 2005-10-31 PT PT05806365T patent/PT1814993E/pt unknown
- 2005-10-31 BR BRPI0517928-9A patent/BRPI0517928A/pt not_active IP Right Cessation
- 2005-10-31 ES ES05806365T patent/ES2339366T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
AU2005300737A1 (en) | 2006-05-11 |
BRPI0517928A (pt) | 2008-10-21 |
DE602005018812D1 (de) | 2010-02-25 |
CN101065486A (zh) | 2007-10-31 |
ES2339366T3 (es) | 2010-05-19 |
EP1814993A1 (de) | 2007-08-08 |
ES2325344B1 (es) | 2010-06-09 |
JP2008527974A (ja) | 2008-07-31 |
CA2585282A1 (en) | 2006-05-11 |
RU2007120521A (ru) | 2008-12-10 |
ES2325344A1 (es) | 2009-09-01 |
EP1814993B1 (de) | 2010-01-06 |
US20070253952A1 (en) | 2007-11-01 |
RU2398878C2 (ru) | 2010-09-10 |
AU2005300737B2 (en) | 2011-05-19 |
PT1814993E (pt) | 2010-04-12 |
CN101065486B (zh) | 2011-08-31 |
WO2006048252A1 (en) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE454454T1 (de) | Multifunktionelle und multivalente angiogenese- inhibitoren | |
CR20220396A (es) | Anticuerpos y proteínas de fusión que se unen a ccr8 y usos de estos | |
CY1116964T1 (el) | Μονοκλωνικα αντισωματα εναντι claudin-18 στην αγωγη εναντι καρκινου | |
NO20080626L (no) | Inhibitorer av fibroblastaktiverende protein alfa | |
ATE432281T1 (de) | Pyrrolotriazin-kinasehemmer | |
WO2007115837A3 (en) | Combination of an anti-edb fibronectin domain antibody/ il2 fusion protein and a further small molecule | |
JO3134B1 (ar) | مثبطات نشاط akt | |
BRPI0512722A (pt) | inibidores de cinase heterocìclica fundida | |
ECSP067014A (es) | Modulación de producción de inmunoglobulina y trastornos atópicos | |
EA200900091A1 (ru) | Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний | |
EA200801301A1 (ru) | ИНГИБИТОРЫ АКТИВНОСТИ Akt | |
BRPI0809583A2 (pt) | polipeptídeos fgf-21 modificados e seus usos | |
BR0314814A (pt) | Variantes otimizadas de fc e métodos para sua geração | |
ECSP088733A (es) | Anticuerpos anti-5t4 y usos de los mismos | |
CL2008001234A1 (es) | Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer. | |
EA200870411A1 (ru) | Полипептиды с усиленным противовоспалительным и пониженным цитотоксическим свойствами и связанные с ними способы | |
WO2009009173A3 (en) | Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases | |
BRPI0408247A (pt) | usos de antagonistas e agonistas de il-23 e reagentes relacionados | |
NO20082240L (no) | GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser | |
EA201991409A2 (ru) | Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения | |
EA200400235A1 (ru) | Комбинированная терапия для лечения рака | |
NO20055210D0 (no) | Inhibitorproteiner av en protease og anvendelse derav | |
CR20230314A (es) | N-(2-(4-cianotiazolidin-3-il)-2-oxoetil)-quinolin-4-carboxamidas | |
WO2007076320A3 (en) | Compounds | |
WO2007138455A3 (en) | Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |